These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33509004)

  • 1. Cubogel as potential platform for glaucoma management.
    Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
    Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug.
    Sayed S; Abdelmoteleb M; Amin MM; Khowessah OM
    AAPS PharmSciTech; 2020 Feb; 21(3):87. PubMed ID: 32016607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
    Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
    Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
    Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
    Sharma PK; Chauhan MK
    Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
    [No Abstract]   [Full Text] [Related]  

  • 7. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M; Mahmoodzadeh M; Farrahi F
    AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures.
    Afify EAMR; Elsayed I; Gad MK; Mohamed MI; Afify AEMR
    PLoS One; 2018; 13(2):e0191415. PubMed ID: 29401498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation.
    Sayed S; Habib BA; Elsayed GM
    J Liposome Res; 2018 Sep; 28(3):182-192. PubMed ID: 28480807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
    Ahirrao M; Shrotriya S
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of
    Nawaz M; Hayat S; Farooq U; Iqbal MA; Khalid SH; Nee TW; Khaw KY; Munir R; Ijaz MU
    RSC Adv; 2024 Oct; 14(44):32008-32020. PubMed ID: 39391623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
    Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
    Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.
    Naguib MJ; Elsayed I; Teaima MH
    Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
    Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
    Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.